Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Hancock

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of cationic peptidesR E Hancock
The Lancet. Infectious Diseases|March 2, 2002
Cationic peptides: effectors in innate immunity and novel antimicrobialsR E Hancock
Drugs|May 11, 1999
Host defence (cationic) peptides: what is their future clinical potential?R E Hancock
Nature Genetics|December 1, 2001
A brief on bacterial biofilmsR E Hancock
The Journal of Antimicrobial Chemotherapy|December 1, 1981
Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cellsR E Hancock
Trends in Microbiology|January 1, 1997
The bacterial outer membrane as a drug barrierR E Hancock
Methods in Molecular Medicine|February 26, 2011
Isolation and Characterization of Porins from H. pyloriR E Hancock, M Exner
Behring Institute Mitteilungen|February 1, 1997
Potential of protein OprF of Pseudomonas in bivalent vaccinesR E Hancock, R Wong
Antimicrobial Agents and Chemotherapy|August 1, 1995
Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3X Liao, R E Hancock
Antimicrobial Agents and Chemotherapy|May 1, 1997
Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3X Liao, R E Hancock
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of cationic peptidesR E Hancock
The Lancet. Infectious Diseases|March 2, 2002
Cationic peptides: effectors in innate immunity and novel antimicrobialsR E Hancock
Drugs|May 11, 1999
Host defence (cationic) peptides: what is their future clinical potential?R E Hancock
Nature Genetics|December 1, 2001
A brief on bacterial biofilmsR E Hancock
The Journal of Antimicrobial Chemotherapy|December 1, 1981
Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cellsR E Hancock
Trends in Microbiology|January 1, 1997
The bacterial outer membrane as a drug barrierR E Hancock
Methods in Molecular Medicine|February 26, 2011
Isolation and Characterization of Porins from H. pyloriR E Hancock, M Exner
Behring Institute Mitteilungen|February 1, 1997
Potential of protein OprF of Pseudomonas in bivalent vaccinesR E Hancock, R Wong
Antimicrobial Agents and Chemotherapy|August 1, 1995
Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3X Liao, R E Hancock
Antimicrobial Agents and Chemotherapy|May 1, 1997
Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3X Liao, R E Hancock
Pageof 24